Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs)

Lung Cancer

Volumn 45, Issue 3, 2004, Pages 325-337

  Ishii, Haruhiko ^a   Yazawa, Takuya ^a   Sato, Hanako ^a   Suzuki, Takehisa ^a   Ikeda, Masaichi ^a   Hayashi, Yasufumi ^a   Takanashi, Yoshinori ^a   Kitamura, Hitoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Intrathoracic lung cancer cells; Lung cancer; Lymph node metastasis; Lymphangiogenesis; Pleural dissemination; Pleural effusion; Vascular endothelial growth factors (VEGFs)

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; CANCER CELL; CANCER INFILTRATION; CAPILLARY; CARCINOGENESIS; CELL CULTURE; CELL FUNCTION; CELL LINE; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; LUNG CANCER; LUNG INJURY; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PLEURA EFFUSION; PLEURA METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; THORACIC CAVITY; TUMOR GROWTH; TUMOR LOCALIZATION;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PLEURAL NEOPLASMS; PROGNOSIS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 3843135260     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.02.021     Document Type: Article

References (51)

1. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18:1997;4-25
2. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:1999;9-22
3. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., rauvala H., et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 276:1997;1423-1425
4. Rissanen T.T., Markkanen J.E., Gruchala M., Heikura T., Puranen A., Kettunen M.I., et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92:2003;1098-1106
5. Gale N.W., Yancopoulos G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13:1999;1055-1066
6. Niki T., Iba S., Tokunou M., Yamada T., Matsuno Y., Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin. Cancer Res. 6:2000;2431-2439
7. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9:2003;669-676
8. Fontanini G., Vignati S., Boldrini L., Chine S., Silvestri V., Lucchi M., et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin. Cancer Res. 3:1997;861-865
9. Shibusa T., Shijubo N., Abe S. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin. Cancer Res. 4:1998;1483-1487
10. O'Byrne K.J., Koukourakis M.I., Giatromanolaki A., Cox G., Turley H., Steward W.P., et al. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br. J. Cancer. 82:2000;1427-1432
11. Han H., Silverman J.F., Santucci T.S., Macherey R.S., d'Amato T.A., Tung M.Y., et al. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann. Surg. Oncol. 8:2001;72-79
12. Tsao M.S., Liu N., Nicklee T., Shepherd F., Viallet J. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma. Clin. Cancer Res. 3:1997;1807-1814
13. Decaussin M., Sartelet H., Robert C., Moro D., Claraz C., Brambilla C., et al. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. J. Pathol. 188:1999;369-377
14. Yano S., Shinohara H., Herbst R.S., Kuniyasu H., Bucana C.D., Ellis L.M., et al. Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells. Am. J. Pathol. 157:2000;1893-1903
15. Luo J.C., Yamaguchi S., Shinkai A., Shitara K., Shibuya M. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors. Cancer Res. 58:1998;2652-2660
16. Yoneda J., Kuniyasu H., Crispens M.A., Price J.E., Bucana C.D., Fidler I.J. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst. 90:1998;447-454
17. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7:2001;192-198
18. Mattila M.M.-T., Ruohola J.K., Karpanen T., Jackson D.G., Alitalo K., Harkonen P.L., et al. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int. J. Cancer. 98:2002;946-951
19. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7:2001;186-191
20. Yanai Y., Furuhata T., Kimura Y., Yamaguchi K., Yasoshima T., Mitaka T., et al. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice. J. Exp. Clin. Cancer Res. 20:2001;419-428
21. Ishikawa M., Kitayama J., Kazama S., Nagawa H. Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn. J. Clin. Oncol. 33:2003;21-27
22. Kishimoto K., Sasaki A., Yoshihama Y., Mese H., Tsukamoto G., Matsumura T. Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma. Oral Oncol. 39:2003;391-396
23. Kajita T., Ohta Y., Kimura K., Tamura M., Tanaka Y., Tsunezuka Y., et al. The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br. J. Cancer. 85:2001;255-260
24. White J.D., Hewett P.W., Kusuge D., McCulloch T., Enholm B.C., Carmichael J., et al. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res. 62:2002;1669-1675
25. Yokoyama Y., Charnock-Jones D.S., Licence D., Yanaihara A., Hastings J.M., Holland C.M., et al. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin. Cancer Res. 9:2003;1361-1369
26. Arinaga M., Noguchi T., Takeno S., Chujo M., Miura T., Uchida Y. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer. 97:2003;457-464
27. Yokoyama Y., Charnock-Jones D.S., Licence D., Yanaihara A., Hastings J.M., Holland C.M., et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br. J. Cancer. 88:2003;237-244
28. Funaki H., Nishimura G., Harada S., Ninomiya I., Terada I., Fushida S., et al. Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma. Oncology. 64:2003;416-422
29. Yano S., Herbst R.S., Shinohara H., Knighton B., Bucana C.D., Killion J.J., et al. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clin. Cancer Res. 6:2000;957-965
30. Ohta Y., Kimura K., Tamura M., Oda M., Tanaka M., Sasaki T., et al. Biological characteristics of carcinomatosa pleuritis in orthotopic model systems using immune-defficient rats. Int. J. Oncol. 18:2001;499-505
31. Shinkaruk S., Bayle M., Lain G., Deleris G. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy. Curr. Med. Chem. Anti-Cancer Agents. 3:2003;95-117
32. Schlaeppi J.M., Wood J.M. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors. Cancer Metastasis Rev. 18:1999;473-481
33. Wood J.M. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Medicina. 60:2000;41-47
34. Luo J.C., Toyoda M., Shibuya M. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody. Cancer Res. 58:1998;2594-2600
35. Hu L., Hofmann J., Zaloudek C., Ferrara N., Hamilton T., Jaffe R.B. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer. Am. J. Pathol. 161:2002;1917-1924
36. Zhang W., Ran S., Sambade M., Huang X., Thorpe P.E. A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model. Angiogenesis. 5:2002;35-44
37. Kamiyama M., Ichikawa Y., Ishikawa T., Chishima T., Hasegawa S., Hamaguchi Y., et al. VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice. Cancer Gene Ther. 9:2002;197-201
38. Kondo Y., Arii S., Mori A., Furutani M., Chiba T., Imamura M. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line. Clin. Cancer Res. 6:2000;622-630
39. Akutagawa N., Nishikawa A., Iwasaki M., Fujimoto T., Teramoto M., Kitajima Y., et al. Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model. Jpn. J. Cancer Res. 93:2002;644-651
40. Townson S., Lagercrantz J., Grimmond S., Silins G., Nordenskjold M., Weber G., et al. Characterization of the murine VEGF-related factor gene. Biochem. Biophys. Res. Commun. 220:1996;922-928
41. Yamada Y., Nezu J., Shimane M., Hirata Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics. 42:1997;483-488
42. LeCouter J., Lin R., Frantz G., Zhang Z., Hillan K., Ferrara N. Mouse endocrine gland-derived vascular endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis. Endocrinology. 144:2003;2606-2616
43. Yazawa T., Ito T., Kamma H., Suzuki T., Okudela K., Hayashi H., et al. Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma. Am. J. Pathol. 161:2002;291-300
44. Yazawa T., Kamma H., Fujiwara M., Matsui M., Horiguchi H., Satoh H., et al. Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer. J. Pathol. 187:1999;191-199
45. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1-8
46. Ohta Y., Tanaka Y., Hara T., Oda M., Watanabe S., Shimizu J., et al. Clinicopathological and biological assessment of lung cancers with pleural dissemination. Ann. Thorac. Surg. 69:2000;1025-1029
47. Grove C.S., Lee Y.C. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr. Opin. Pulm. Med. 8:2002;294-301
48. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., et al. Vascular endothelial growth factor-C mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20:2001;672-682
49. He Y., Kozaki K., Karpanen T., Koshikawa K., Yla-Herttuala S., Takahashi T., et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer Inst. 94:2002;819-825
50. Valtola R., Salven P., Heikkila P., Taipale J., Joensuu H., Rehn M., et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 154:1999;1381-1390
51. Krishnan J., Kirkin V., Steffen A., Hegen M., Weih D., Tomarev S., et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res. 63:2003;713-722